Oosterholt SP - Search Results

1

Population pharmacokinetics of raxibacumab in healthy adult subjects.

Oosterholt SP, Della Pasqua O. Oosterholt SP, et al. Br J Clin Pharmacol. 2021 Dec;87(12):4718-4725. doi: 10.1111/bcp.14894. Epub 2021 Jul 14. Br J Clin Pharmacol. 2021. PMID: 33973655 Free article. Clinical Trial.

2

Biomarker exposure-response relationships as the basis for rational dose selection: Lessons from a simulation exercise using a selective COX-2 inhibitor.

Taneja A, Oosterholt SP, Danhof M, Della Pasqua O. Taneja A, et al. Among authors: oosterholt sp. J Clin Pharmacol. 2016 May;56(5):609-21. doi: 10.1002/jcph.629. Epub 2015 Dec 27. J Clin Pharmacol. 2016. PMID: 26331692 Clinical Trial.

3

Population pharmacokinetics of NNZ-2566 in healthy subjects.

Oosterholt SP, Horrigan J, Jones N, Glass L, Della Pasqua O. Oosterholt SP, et al. Eur J Pharm Sci. 2017 Nov 15;109S:S98-S107. doi: 10.1016/j.ejps.2017.05.032. Epub 2017 May 15. Eur J Pharm Sci. 2017. PMID: 28522374 Clinical Trial.

4

Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura.

Taylor A, Vendramin C, Oosterholt S, Della Pasqua O, Scully M. Taylor A, et al. J Thromb Haemost. 2019 Jan;17(1):88-98. doi: 10.1111/jth.14345. Epub 2018 Dec 31. J Thromb Haemost. 2019. PMID: 30475428 Free article.

5

Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome.

Glaze DG, Neul JL, Kaufmann WE, Berry-Kravis E, Condon S, Stoms G, Oosterholt S, Della Pasqua O, Glass L, Jones NE, Percy AK; Rett 002 Study Group. Glaze DG, et al. Neurology. 2019 Apr 16;92(16):e1912-e1925. doi: 10.1212/WNL.0000000000007316. Epub 2019 Mar 27. Neurology. 2019. PMID: 30918097 Free PMC article. Clinical Trial.

6

Use of prior knowledge and extrapolation in paediatric drug development: A case study with deferasirox.

Borella E, Oosterholt S, Magni P, Della Pasqua O. Borella E, et al. Eur J Pharm Sci. 2019 Aug 1;136:104931. doi: 10.1016/j.ejps.2019.05.009. Epub 2019 May 18. Eur J Pharm Sci. 2019. PMID: 31108206

7

A Phase 2 Study of AMO-02 (Tideglusib) in Congenital and Childhood-Onset Myotonic Dystrophy Type 1 (DM1).

Horrigan J, Gomes TB, Snape M, Nikolenko N, McMorn A, Evans S, Yaroshinsky A, Della Pasqua O, Oosterholt S, Lochmüller H. Horrigan J, et al. Pediatr Neurol. 2020 Nov;112:84-93. doi: 10.1016/j.pediatrneurol.2020.08.001. Epub 2020 Aug 5. Pediatr Neurol. 2020. PMID: 32942085 Free article. Clinical Trial.

8

Extrapolation and dosing recommendations for raxibacumab in children from birth to age <18 years.

Oosterholt SP, Della Pasqua O. Oosterholt SP, et al. Br J Clin Pharmacol. 2021 Dec;87(12):4709-4717. doi: 10.1111/bcp.14893. Epub 2021 Jul 13. Br J Clin Pharmacol. 2021. PMID: 33974281 Free article.

9

Characterisation of individual ferritin response in patients receiving chelation therapy.

Borella E, Oosterholt S, Magni P, Della Pasqua O. Borella E, et al. Br J Clin Pharmacol. 2022 Aug;88(8):3683-3694. doi: 10.1111/bcp.15290. Epub 2022 Mar 26. Br J Clin Pharmacol. 2022. PMID: 35199367 Free PMC article.

10

Cardiac sodium channel inhibition by lamotrigine: In vitro characterization and clinical implications.

Ingleby-Talecki L, van Dijkman SC, Oosterholt SP, Della Pasqua O, Winter C, Cunnington M, Rebar L, Forero-Schwanhaeuser S, Patel V, Cooper JA, Bahinski A, Chaudhary KW. Ingleby-Talecki L, et al. Among authors: oosterholt sp. Clin Transl Sci. 2022 Aug;15(8):1978-1989. doi: 10.1111/cts.13311. Epub 2022 May 31. Clin Transl Sci. 2022. PMID: 35579204 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters